Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Viridian Therapeutics, Inc.
VRDN
Segment Reporting Other Item Amount
Segment Reporting Other Item Amount at other companies
Century Communities
CCS
$22.22M
+279%
EyePoint, Inc.
EYPT
$4.06M
+16.7%
Equitable Holdings
EQH
$371M
-5.1%
Essential Utilities
WTRG
-$75K
+74.4%
Proto Labs
PRLB
$128.08M
+5.2%
ICF International
ICFI
$660K
-31.7%
Segments
By segment
See full
Reportable Segment
-$11.29M
-63.4%
Other financials
Income statement
See full
Revenue
$141.0K
+95.8%
Operating income
-$116.2M
-23.8%
Net income
-$104.9M
-20.7%
EPS (diluted)
-$1.15
-5.5%
Balance sheet
See full
Cash & equivalents
$176.3M
+51.7%
Total debt
$36.8M
+59.4%
Total equity
$636.0M
+5.2%
Total assets
$789.0M
+19.4%
Cash flow
See full
Operating cash flow
-$119.7M
-29.1%
CapEx
$23.0K
-73.3%
Free cash flow
-$119.7M
-29.0%
Valuation
See full
Market cap
$1.91B
+82.0%
Profitability
See full
Gross margin
36.3%
—
Operating margin
-543.9%
-271pp
Net margin
-508.5%
-254pp
FCF margin
-428.4%
-214pp
Returns & leverage
See full
Return on equity
-58.1%
+7.9pp
Debt / equity
0.1×
0.0×
Current ratio
15.1×
-4.3×